Addition of stents to essential list contrary to international norms, says US embassy official.

Following the NPPA decision, some companies have reportedly withdrawn high-priced stents, leading to an artificial shortage of the product.

A cardiologist who spoke to ET on condition of anonymity said some companies, especially importers, have asked hospitals not to use stents ...

There are reports of shortages of stents in hospitals after the government reduced their prices by up to 85 per cent by capping rates of ba...

There have been reports of “artificial” shortage of stents since National Pharmaceutical Pricing Authority (NPPA) capped prices of these li...

The government think-tank Niti Aayog has written to Health Ministry to restructure the entire approval process for innovation in medical re...

The group has termed the move “anti-national” and “anti-people”, adding that it affects an ongoing case at the SC over various aspects of d...

Under the current regime, the moment a drug is brought under the list of essential medicines, it is subject to the price control mechanism.

These were among the 14 prominent changes made at the secretary level on Tuesday by the Appointments Committee of Cabinet headed by the Pri...

18 senior IAS officers have been promoted to the level of Secretary, and some to Special Secretary, by temporarily upgrading the posts held...

Srivastava, a 1980-batch IAS officer of Arunachal Pradesh-Goa-Mizoram-Union Territories (AGMUT) cadre, was working as Special Secretary and...